Publications by authors named "S Colak"
MXene as SERS-Active Substrate: Impact of Intrinsic Properties and Performance Analysis.
ACS Appl Mater Interfaces
December 2024
A new member is incorporated into the SERS active materials family daily as a consequence of advances in materials science. Furthermore, it has been demonstrated that MXenes, which display remarkable physicochemical characteristics, are also encompassed within this family. This Review offers a comprehensive and systematic assessment of the potential of MXene structures in the context of SERS applications.
View Article and Find Full Text PDFBackground: Idiopathic granulomatous mastitis (IGM) is a benign and rare chronic inflammatory disease of the breast. Although there are various treatment modalities, an ideal treatment algorithm has not been defined.
Aims: We designed this study to evaluate the clinical status, duration of remission, remission rates, and treatment algorithm in patients with IGM during a 5-year follow-up period after immunosuppressive therapy.
Introduction: Postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is a frequent complication, and its pathogenesis remains unclear, with various patient and procedural factors proposed as potential contributors. This study aimed to assess the predictive value of pancreatic to splenic density ratio on computed tomography (CT) for PEP in patients with inadvertent pancreatic duct cannulation.
Methods: This retrospective study involved 2556 patients undergoing ERCP from January 2014 to December 2020.
Article Synopsis
- - The research highlights the urgent demand for effective energy storage solutions, leading to the development of a new composite material, CuZnSnS (CZTS) integrated with functionalized Multi-walled Carbon Nanotubes (f-MWCNT) using a hydrothermal method.
- - Three nanocomposite variants (CZTS (10), CZTS (20), CZTS (40)) were produced with different percentages of f-MWCNT, and the CZTS (20) sample showed the best electrochemical performance with a specific capacitance of 171F/g.
- - The study reveals that the CZTS/f-MWCNT nanocomposite retains 99% of its capacity after 3000 cycles, indicating its strong potential for enhancing
Background: Nintedanib reduces the decline of pulmonary function in patients with advancing lung fibrosis.
Aim: To assess the characteristics of the patients with connective tissue diseases (CTDs) related to interstitial lung disease (ILD) under nintedanib treatment.
Methods: The CTD-related ILD patients under nintedanib treatment who were followed up between 2020 and 2023 were included in the study.